We serve 4-(4-chlorobutyl)pyridine,hydrochloride CAS:149463-65-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 4-(4-chlorobutyl)pyridine,hydrochloride
CAS.NO:149463-65-0
Synonyms:
4-(4-PYRIDINYL)BUTYL CHLORIDE HYDROCHLORIDE
4-(4-Chlorobutyl)pyridine hydrochloride
Molecular Formula:C9H13Cl2N
Molecular Weight:206.11200
Physical and Chemical Properties:
Density: /
Boiling point: 311.1ºC at 760 mmHg
Melting point: /
Flash point: 141.9ºC
Refractive index:/
Specification:
Appearance: White powder
Purity:≥99%
Moisture Content: 0.1%
Impurity: 0.06%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Tirofiban Hydrochloride CAS:142373-60-2
Contact us for information like 4-(4-chlorobutyl)pyridine,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(4-Chlorobutyl)pyridine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(4-Chlorobutyl)pyridine hydrochloride Use and application,4-(4-Chlorobutyl)pyridine hydrochloride technical grade,usp/ep/jp grade.
Related News: There are a number of common signs that you may be infected, most of which are respiratory such as experiencing breathing difficulties, shortness of breath and having a cough.2',3',5'-Tri-O-acetyl-D-adenosine manufacturer Ten domestic API leading enterprises of CSPC, Puluo Pharmaceutical, Huahai Pharmaceutical, Chuang Nuo Pharmaceutical, Federal Pharmaceuticals, Zhejiang Pharmaceutical, Yifan Pharmaceutical, Jiangxi Tianxin, Zhejiang Chemical Industry, and Xinhua Pharmaceutical rank among China’s API exporters The top ten in the list.2-Chloroacrylonitrile supplier Oligomannate, which uses extract from marine brown algae as raw material, received a conditional green light to treat mild-to-moderate level AD, the National Medical Products Administration (NMPA) said in a statement on its website late on Saturday.methyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate vendor The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.There’s still a lot we don’t know about the coronavirus, and scientists internationally are racing to gather data and develop a treatment.
